Apoptosis in carcinoma of the bladder: Relation with radiation treatment results

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 5, 1999, Pages 1015-1019

  Lara, Pedro C ^a,b   Pérez, Sofía ^b   Rey, Agustín ^a   Santana, Carlos ^a  

^a Department of Radiation Oncology ^*  (Spain)

^b Research Unit   (Spain)

Author keywords

Apoptosis; Bladder; Radiotherapy

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MITOSIS INDEX; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

ANALYSIS OF VARIANCE; APOPTOSIS; CARCINOMA, TRANSITIONAL CELL; HUMANS; KI-67 ANTIGEN; PROGNOSIS; REFERENCE VALUES; REGRESSION ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0345369643     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00472-6     Document Type: Article

References (25)

1. Montie J.E., Stranffon R.A., Stewart B.H. Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol. 131:1984;477-483.
2. Pollack A., Zagars G.K., Dinney C.P., Swanson D.A., von Eschembach A.C. Preoperative radiotherapy for muscle-invasive bladder carcinoma Long term follow-up and prognostic factors for 3338 patients . Cancer. 74:1994;2819-2827.
3. Rintala E., Hannisdahl E., Fossa S.D., Hellsten S., Sander S. Neoadjuvant chemotherapy in bladder cancer: A randomized study. Nordic Cystectomy Trial I. Scand J Urol Nephrol. 27:1993;355-362.
4. Fossa S.D., Waehre H., Aass N., Jacobsen A.B., Olsen D.R., Ous S. Bladder cancer definitive radiation therapy for muscle invasive bladder cancer A retrospective analysis of 317 patients . Cancer. 72:1993;3036-3043.
5. Gospodarowicz M.K., Rider W.D., Keen C.W. Bladder cancer Long term follow up results of patients treated with radical radiation . Clin Oncol. 3:1991;155-161.
6. Davidson S.E., Symonds R.P., Snee M.P., Upadhyay S., Habeshaw T., Robertson A.G. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol. 66:1990;288-293.
7. Meyn R.E., Stephens L.C., Ang K.K., Hunter N.R., Brock W.A., Milas L., et al. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Radiat Biol. 64:1993;583-591.
8. Chyle V., Pollack A., Czerniak B., Stephens L.C., Zagars G.K., Terry N.H., et al. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 35:1996;281-287.
9. Levine E.L., Davidson S.E., Roberts S.A., Chadwick C., Potten C.S., West C.M.L. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet. 344:1994;472.
10. Levine E.L., Renehan A., Gossiel R., Davidson S.E., Roberts S.A., Chadwick C., et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response to cervical carcinoma. Radiother Oncol. 37:1995;1-9.
11. Wheeler J.A., Stephens L.C., Tornos C., Eifel P., Ang K.K., Milas L., Allen P., et al. Apoptosis as a predictor of tumor response to radiation in stage B cervical carcinoma. Int J Radiat Oncol Biol Phys. 32:1995;1487-1493.
12. Flemming I.D., Cooper J.S., Henson D.E., Hutter R.V.P., Kennedy B.J. American Joint Committee on Cancer staging manual. 5th ed. 1997;JB Lippincott, Philadelphia.
13. World Health Organization. International histologic classification of tumors, 2nd ed. Geneva: World Health Organization, 1969-1981; Berlin: Springer- Verlag, 1988-Present.
14. WHO handbook for reporting results of cancer treatments. World Health Organization offset publication no.48. 1979;World Health Organization, Geneva.
15. Walker N.I., Harmon B.V., Gobe G.C., Kerr J.F.R. Patterns of cell death. Methods Achiev Exp Pathol. 13:1988;18-54.
16. Rey A., Lara P.C., Redondo E., Valdes E., Apolinario R. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival. Cancer. 79:1997;2178-2185.
17. Kaplan E.I., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
18. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Desing and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer. 35:1977;1-39.
19. Cox D.R. Regression models and life-tables. J R Stat Soc (B). 34:1972;187-220.
20. Altman D.G., Lausen B., Sauerbrei W., Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 86:1994;829-835.
21. Lipponen P.K., Altomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol. 173:1994;333-339.
22. King E.D., Matteson J., Jacobs S.C., Kyprianou N. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder Association with tumor progression . J Urol. 155:1996;316-320.
23. Wyllie A.H. Apoptosis (The 1992 Frank Rose Memorial lecture). Br J Cancer. 67:1993;205-208.
24. Corvo R., Giaretti W., Geido E., Sanguinetti G., Orecchia R., Scala M., et al. Cell kinetics and tumor regression during radiotherapy in head and neck squamous cell carcinomas. Int J Cancer. 68:1996;151-155.
25. Oltvai Z.N., Millman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell. 74:1995;609-619.